FXAIX
Price
$265.83
Change
-$2.30 (-0.86%)
Updated
Aug 20 closing price
Net Assets
833.14B
MLVAX
Price
$19.26
Change
+$0.10 (+0.52%)
Updated
Aug 21 closing price
Net Assets
317.32M
Interact to see
Advertisement

FXAIX vs MLVAX

FXAIX vs MLVAX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. MLVAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a StrongBuy and MLVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 833B vs. MLVAX (317M). FXAIX pays higher dividends than MLVAX: FXAIX (1.06) vs MLVAX (0.67). FXAIX was incepted earlier than MLVAX: FXAIX (15 years) vs MLVAX (13 years). MLVAX (0.93) is less costly to investors than FXAIX (0.01). MLVAX is a more actively managed with annual turnover of: 23.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than MLVAX: FXAIX (0) vs MLVAX (1000). FXAIX annual gain was more profitable for investors over the last year : 21.35 vs. MLVAX (-2.14). FXAIX return over 5 years is better than : 84.67 vs. MLVAX (-11.19).
FXAIXMLVAXFXAIX / MLVAX
Total Expense Ratio0.010.892%
Annual Report Gross Expense Ratio0.010.932%
Fund Existence15 years13 years-
Gain YTD12.4379.322133%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets833B317M262,776%
Annual Yield % from dividends1.060.67157%
Returns for 1 year21.35-2.14-996%
Returns for 3 years81.157.951,020%
Returns for 5 years84.67-11.19-757%
Returns for 10 years286.5764.37445%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCFX55.570.84
+1.53%
Rydex Biotechnology C
RSLBX70.040.57
+0.82%
American Funds SMALLCAP World R-2
RYPNX20.180.16
+0.80%
Royce Small-Cap Opportunity Invmt
VSORX54.480.35
+0.65%
Victory Sycamore Small Company Opp R6
BLNIX15.060.05
+0.33%
Meeder Balanced Institutional